Bio-Rad Laboratories Class BBIO.B
13F holders, Q2 2026 (June 30)5holders −2
0new positions
2sold out
$300.23avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holders were Flow Traders U.S. LLC ($229K), Morgan Stanley ($214K) and Wells Fargo & Company ($50K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $483K |
All 13F filers, Q1 2026 → Q2 2026: 1,962 shares sold, net −1,962 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Flow Traders U.S. LLC | 0.01% | Reduce -22.8% | 760 | $229K |
| Morgan Stanley | 0.00% | No change | 712 | $214K |
| Wells Fargo & Company | 0.00% | No change | 170 | $50K |
| Whittier Trust Co. | 0.00% | No change | 160 | $47K |
| UBS Group AG | 0.00% | No change | 13 | $4K |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.